Format

Send to

Choose Destination
Ann Oncol. 2016 Feb;27(2):353-6. doi: 10.1093/annonc/mdv547. Epub 2015 Nov 16.

Access to innovative oncology medicines in Europe.

Author information

1
Department of Medical Clinic II, University Hospital, Frankfurt l.bergmann@em.uni-frankfurt.de.
2
Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
3
NDA Advisory Services Ltd, Prime House, Leatherhead, Surrey, UK.
4
Law Office, Cologne, Germany.
5
Pfizer Business Unit Oncology Europe/Africa/Middle East, Brussels, Belgium.
6
Department of Internal Medicine, University Hospital, Innsbruck, Austria.
PMID:
26578739
PMCID:
PMC4722892
DOI:
10.1093/annonc/mdv547
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center